Interventions for structural heart disease

Double device left atrial appendage closure

EuroIntervention 2015;11:470-476 published online ahead of print July 2014. DOI: 10.4244/EIJY14M07_03

Ênio E. Guérios1,2, MD; Steffen Gloekler1, MD; Michael Schmid1, MD; Ahmed Khattab1, MD; Fabian Nietlispach1, MD; Bernhard Meier1*, MD

1. Department of Cardiology, Bern University Hospital, Bern, Switzerland; 2. Concept - Centro de Cardiopatias Congênitas e Estruturais do Paraná, Curitiba, Brazil

Aims: Percutaneous left atrial appendage (LAA) occlusion is an alternative to oral anticoagulation for the prevention of stroke in patients with non-valvular atrial fibrillation (NVAF). D

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

atrial fibrillationclosure devicesleft atrial appendage

Share on Facebook Share on Twitter Share on Linkedin

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

October 19, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.

Transcatheter Paravalvular Leak Closure: Catch Me If You Can

Thomas Pilgrim et al.

October 20, 2021

STATE OF THE ART

Glucose-Lowering Therapy in Patients undergoing Percutaneous Coronary Intervention

Isabelle Johansson et al.